Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Corey–Bloom J[au]:

Total recognition discriminability in Huntington's and Alzheimer's disease. Graves LV et al. J Clin Exp Neuropsychol. (2017)

Everyday Functioning in Huntington's Disease: A Laboratory-Based Study of Financial Management Capacity. Sheppard DP et al. Appl Neuropsychol Adult. (2017)

Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease. Sumida CA et al. Arch Clin Neuropsychol. (2018)

Search results

Items: 1 to 50 of 122

1.

New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Gilbert PE, Delis DC.

J Int Neuropsychol Soc. 2019 May 7:1-6. doi: 10.1017/S1355617719000407. [Epub ahead of print]

PMID:
31060638
2.

Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3.

Graves LV, Simone S, Williams M, Courville T, Mattson SN, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

Appl Neuropsychol Adult. 2019 May 6:1-8. doi: 10.1080/23279095.2019.1605993. [Epub ahead of print]

PMID:
31060389
3.

Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease.

Sumida CA, Van Etten EJ, Lopez FV, Sheppard DP, Pirogovsky-Turk E, Corey-Bloom J, Filoteo JV, Woods SP, Gilbert PE, Schmitter-Edgecombe M.

Arch Clin Neuropsychol. 2018 Dec 5. doi: 10.1093/arclin/acy093. [Epub ahead of print]

PMID:
30517595
4.

New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

J Int Neuropsychol Soc. 2018 Sep;24(8):833-841. doi: 10.1017/S1355617718000474. Epub 2018 Aug 16.

5.

Salivary levels of total huntingtin are elevated in Huntington's disease patients.

Corey-Bloom J, Haque AS, Park S, Nathan AS, Baker RW, Thomas EA.

Sci Rep. 2018 May 9;8(1):7371. doi: 10.1038/s41598-018-25095-3.

6.

Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging.

Graves LV, Van Etten EJ, Holden HM, Delano-Wood L, Bondi MW, Corey-Bloom J, Delis DC, Gilbert PE.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Sep;25(5):767-782. doi: 10.1080/13825585.2017.1372358. Epub 2017 Aug 31.

PMID:
28857679
7.

Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy.

Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J.

Appl Neuropsychol Adult. 2019 Jan-Feb;26(1):17-27. doi: 10.1080/23279095.2017.1353993. Epub 2017 Aug 29.

PMID:
28850256
8.

Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms.

Corey-Bloom J, Aikin AM, Gutierrez AM, Nadhem JS, Howell TL, Thomas EA.

Brain Res. 2017 Oct 15;1673:102-110. doi: 10.1016/j.brainres.2017.08.013. Epub 2017 Aug 18.

9.

Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study.

Sheth VR, Fan S, He Q, Ma Y, Annese J, Switzer R, Corey-Bloom J, Bydder GM, Du J.

Magn Reson Imaging. 2017 May;38:87-94. doi: 10.1016/j.mri.2016.12.025. Epub 2016 Dec 28.

10.

Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases.

Van Liew C, Santoro MS, Goldstein J, Gluhm S, Gilbert PE, Corey-Bloom J.

Am J Alzheimers Dis Other Demen. 2016 Dec;31(8):658-663. Epub 2016 Sep 26.

PMID:
27678491
11.

Obstructive Sleep Apnea and Cognition in Parkinson's disease.

Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S.

Sleep Med. 2016 May;21:28-34. doi: 10.1016/j.sleep.2016.01.001. Epub 2016 Feb 10.

12.

Total recognition discriminability in Huntington's and Alzheimer's disease.

Graves LV, Holden HM, Delano-Wood L, Bondi MW, Woods SP, Corey-Bloom J, Salmon DP, Delis DC, Gilbert PE.

J Clin Exp Neuropsychol. 2017 Mar;39(2):120-130. doi: 10.1080/13803395.2016.1204993. Epub 2016 Jul 21.

13.

Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.

Sheth V, Shao H, Chen J, Vandenberg S, Corey-Bloom J, Bydder GM, Du J.

Neuroimage. 2016 Aug 1;136:37-44. doi: 10.1016/j.neuroimage.2016.05.012. Epub 2016 May 5.

14.

Everyday Functioning in Huntington's Disease: A Laboratory-Based Study of Financial Management Capacity.

Sheppard DP, Pirogovsky-Turk E, Woods SP, Holden HM, Nicoll DR, Filoteo JV, Corey-Bloom J, Gilbert PE.

Appl Neuropsychol Adult. 2017 Mar-Apr;24(2):176-182. doi: 10.1080/23279095.2015.1125904. Epub 2016 Apr 14.

PMID:
27077945
15.

Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease.

Corey-Bloom J, Gluhm S, Herndon A, Haque AS, Park S, Gilbert PE.

J Huntingtons Dis. 2016;5(1):91-6. doi: 10.3233/JHD-150175.

PMID:
27003664
16.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

PMID:
26569098
17.

Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease.

Corey-Bloom J, Jia H, Aikin AM, Thomas EA.

J Huntingtons Dis. 2014;3(3):311-6. doi: 10.3233/JHD-140110.

18.

Measurement of T1 of the ultrashort T2* components in white matter of the brain at 3T.

Du J, Sheth V, He Q, Carl M, Chen J, Corey-Bloom J, Bydder GM.

PLoS One. 2014 Aug 5;9(8):e103296. doi: 10.1371/journal.pone.0103296. eCollection 2014.

19.

Cognitive functioning in complicated grief.

Hall CA, Reynolds CF 3rd, Butters M, Zisook S, Simon N, Corey-Bloom J, Lebowitz BD, Begley A, Mauro C, Shear MK.

J Psychiatr Res. 2014 Nov;58:20-5. doi: 10.1016/j.jpsychires.2014.07.002. Epub 2014 Jul 15.

20.

Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.

Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S.

Sleep Med. 2014 Aug;15(8):959-66. doi: 10.1016/j.sleep.2014.04.009. Epub 2014 May 10.

21.

Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.

Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S.

Sleep. 2014 Jan 1;37(1):177-85. doi: 10.5665/sleep.3332.

22.

"Forgetting to remember" in Huntington's disease: a study of laboratory, semi-naturalistic, and self-perceptions of prospective memory.

Nicoll DR, Pirogovsky E, Woods SP, Holden HM, Filoteo JV, Gluhm S, Corey-Bloom J, Gilbert PE.

J Int Neuropsychol Soc. 2014 Feb;20(2):192-9. doi: 10.1017/S1355617713001355. Epub 2013 Dec 19.

PMID:
24351166
23.

The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease.

Pirogovsky E, Nicoll DR, Challener DM, Breen E, Gluhm S, Corey-Bloom J, Gilbert PE.

J Neuropsychol. 2015 Mar;9(1):77-86. doi: 10.1111/jnp.12036. Epub 2013 Dec 11.

PMID:
24330469
24.

The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.

Van Liew C, Gluhm S, Goldstein J, Cronan TA, Corey-Bloom J.

Psychiatry. 2013 Winter;76(4):323-35. doi: 10.1521/psyc.2013.76.4.323.

PMID:
24299091
25.

Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S.

J Clin Sleep Med. 2013 Nov 15;9(11):1119-29. doi: 10.5664/jcsm.3148.

26.

Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner.

Du J, Ma G, Li S, Carl M, Szeverenyi NM, VandenBerg S, Corey-Bloom J, Bydder GM.

Neuroimage. 2014 Feb 15;87:32-41. doi: 10.1016/j.neuroimage.2013.10.053. Epub 2013 Nov 2.

27.

Proactive selective response suppression is implemented via the basal ganglia.

Majid DS, Cai W, Corey-Bloom J, Aron AR.

J Neurosci. 2013 Aug 14;33(33):13259-69. doi: 10.1523/JNEUROSCI.5651-12.2013.

28.

Actigraphy for the assessment of sleep measures in Parkinson's disease.

Maglione JE, Liu L, Neikrug AB, Poon T, Natarajan L, Calderon J, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S.

Sleep. 2013 Aug 1;36(8):1209-17. doi: 10.5665/sleep.2888.

29.

Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.

Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J.

Mov Disord. 2013 Oct;28(12):1744-7. doi: 10.1002/mds.25578. Epub 2013 Jun 24.

30.

Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan.

Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J.

Cogn Behav Neurol. 2013 Mar;26(1):1-5. doi: 10.1097/WNN.0b013e31828b7d26.

31.

Postural limits of stability in premanifest and manifest Huntington's disease.

Medina LD, Pirogovsky E, Salomonczyk D, Goldstein J, Panzera R, Gluhm S, Simmons R, Corey-Bloom J, Gilbert PE.

J Huntingtons Dis. 2013;2(2):177-84. doi: 10.3233/JHD-130048.

PMID:
25063514
32.

The effect of interference on temporal order memory in premanifest and manifest Huntington's disease.

Nicoll DR, Pirogovsky E, Collazo AE, Tierney SM, Corey-Bloom J, Gilbert PE.

J Huntingtons Dis. 2013;2(3):297-304. doi: 10.3233/JHD-130064.

33.

Difficulty modifying a sustained motor response in prodromal Huntington's disease.

Mickes L, Wixted JT, Peavy GM, Jacobson MW, Goldstein JL, Corey-Bloom J.

J Clin Exp Neuropsychol. 2013;35(1):35-40. doi: 10.1080/13803395.2012.742039. Epub 2012 Dec 3.

PMID:
23198997
34.

Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease.

Covassin N, Neikrug AB, Liu L, Maglione J, Natarajan L, Corey-Bloom J, Loredo JS, Palmer BW, Redwine LS, Ancoli-Israel S.

Auton Neurosci. 2012 Nov 2;171(1-2):85-8. doi: 10.1016/j.autneu.2012.10.003. Epub 2012 Nov 8.

35.

Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort.

Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS Jr, Helmers SL, Factor SA, Jones R, Testa CM.

Mov Disord. 2012 Dec;27(14):1797-800. doi: 10.1002/mds.25237. Epub 2012 Nov 2.

PMID:
23124580
36.

Changes on brief cognitive instruments over time in Parkinson's disease.

Lessig S, Nie D, Xu R, Corey-Bloom J.

Mov Disord. 2012 Aug;27(9):1125-8. doi: 10.1002/mds.25070. Epub 2012 Jun 12.

PMID:
22692724
37.

Clinical severity of Huntington's disease does not always correlate with neuropathologic stage.

Pillai JA, Hansen LA, Masliah E, Goldstein JL, Edland SD, Corey-Bloom J.

Mov Disord. 2012 Aug;27(9):1099-103. doi: 10.1002/mds.25026. Epub 2012 Jun 1.

38.

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.

Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B.

CMAJ. 2012 Jul 10;184(10):1143-50. doi: 10.1503/cmaj.110837. Epub 2012 May 14.

39.

Spongiform change in dementia with Lewy bodies and Alzheimer disease.

Sherzai A, Edland SD, Masliah E, Hansen L, Pizzo DP, Sherzai A, Corey-Bloom J.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):157-61. doi: 10.1097/WAD.0b013e318256d507.

PMID:
22546782
40.

Clinical correlates of periodic limb movements in sleep in Parkinson's disease.

Covassin N, Neikrug AB, Liu L, Corey-Bloom J, Loredo JS, Palmer BW, Maglione J, Ancoli-Israel S.

J Neurol Sci. 2012 May 15;316(1-2):131-6. doi: 10.1016/j.jns.2012.01.004. Epub 2012 Jan 25.

41.

Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease.

Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB.

Neuroimage. 2012 Feb 1;59(3):2452-63. doi: 10.1016/j.neuroimage.2011.08.105. Epub 2011 Sep 10.

42.

Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.

Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM.

Mov Disord. 2011 Dec;26(14):2544-51. doi: 10.1002/mds.23912. Epub 2011 Sep 19.

43.

Treatment trials in aging and mild cognitive impairment.

Corey-Bloom J.

Curr Top Behav Neurosci. 2012;10:347-56. doi: 10.1007/7854_2011_153. Review.

PMID:
21786037
44.

Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease.

Turner TH, Goldstein J, Hamilton JM, Jacobson M, Pirogovsky E, Peavy G, Corey-Bloom J.

J Mot Behav. 2011;43(4):295-302. doi: 10.1080/00222895.2011.580390. Epub 2011 Jun 24.

45.

Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year.

Majid DS, Stoffers D, Sheldon S, Hamza S, Thompson WK, Goldstein J, Corey-Bloom J, Aron AR.

Mov Disord. 2011 Jul;26(8):1481-8. doi: 10.1002/mds.23656. Epub 2011 Apr 11.

46.

Postural deficits in Huntington's disease when performing motor skills involved in daily living.

Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE.

Gait Posture. 2011 Mar;33(3):457-61. doi: 10.1016/j.gaitpost.2010.12.025. Epub 2011 Jan 20.

PMID:
21256027
47.

Impaired postural stability as a marker of premanifest Huntington's disease.

Salomonczyk D, Panzera R, Pirogovosky E, Goldstein J, Corey-Bloom J, Simmons R, Gilbert PE.

Mov Disord. 2010 Oct 30;25(14):2428-33. doi: 10.1002/mds.23309.

PMID:
20818666
48.

A comparison of two brief screening measures of cognitive impairment in Huntington's disease.

Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-Bloom J.

Mov Disord. 2010 Oct 15;25(13):2229-33. doi: 10.1002/mds.23181.

PMID:
20721924
49.

Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J.

Mov Disord. 2010 Jul 15;25(9):1163-9. doi: 10.1002/mds.22953.

50.

Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques.

Rizk-Jackson A, Stoffers D, Sheldon S, Kuperman J, Dale A, Goldstein J, Corey-Bloom J, Poldrack RA, Aron AR.

Neuroimage. 2011 May 15;56(2):788-96. doi: 10.1016/j.neuroimage.2010.04.273. Epub 2010 May 6.

PMID:
20451620

Supplemental Content

Loading ...
Support Center